Byrne Asset Management LLC Invests $658,000 in SPDR S&P Biotech ETF $XBI

Byrne Asset Management LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, HoldingsChannel reports. The fund purchased 5,399 shares of the exchange traded fund’s stock, valued at approximately $658,000.

A number of other institutional investors also recently modified their holdings of the business. AQR Capital Management LLC grew its stake in SPDR S&P Biotech ETF by 77.1% in the 1st quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after buying an additional 2,167 shares in the last quarter. AlphaCore Capital LLC lifted its position in shares of SPDR S&P Biotech ETF by 6,650.0% during the second quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock worth $45,000 after acquiring an additional 532 shares in the last quarter. Global Retirement Partners LLC bought a new position in shares of SPDR S&P Biotech ETF in the second quarter worth $524,000. J.W. Cole Advisors Inc. grew its position in shares of SPDR S&P Biotech ETF by 1.5% in the second quarter. J.W. Cole Advisors Inc. now owns 36,547 shares of the exchange traded fund’s stock valued at $3,031,000 after purchasing an additional 540 shares in the last quarter. Finally, Himension Capital Singapore PTE. LTD. purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at $12,560,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $123.92 on Thursday. The business’s fifty day moving average is $125.18 and its 200 day moving average is $116.87. The firm has a market cap of $8.28 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $132.09.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.